A detailed history of Sippican Capital Advisors transactions in Davita Inc. stock. As of the latest transaction made, Sippican Capital Advisors holds 10,356 shares of DVA stock, worth $1.63 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
10,356
Previous 10,465 1.04%
Holding current value
$1.63 Million
Previous $1.72 Million 9.74%
% of portfolio
1.22%
Previous 1.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$139.81 - $167.96 $15,239 - $18,307
-109 Reduced 1.04%
10,356 $1.55 Million
Q3 2024

Oct 28, 2024

SELL
$133.98 - $165.19 $70,875 - $87,385
-529 Reduced 4.81%
10,465 $1.72 Million
Q2 2024

Aug 06, 2024

SELL
$126.11 - $147.14 $16,520 - $19,275
-131 Reduced 1.18%
10,994 $1.52 Million
Q1 2024

May 02, 2024

SELL
$103.89 - $139.21 $466,777 - $625,470
-4,493 Reduced 28.77%
11,125 $1.54 Million
Q4 2023

Jan 30, 2024

BUY
$73.2 - $108.8 $182,707 - $271,564
2,496 Added 19.02%
15,618 $1.64 Million
Q3 2023

Oct 24, 2023

SELL
$94.53 - $112.68 $72,788 - $86,763
-770 Reduced 5.54%
13,122 $1.24 Million
Q2 2023

Aug 15, 2023

SELL
$81.58 - $100.93 $20,476 - $25,333
-251 Reduced 1.77%
13,892 $1.4 Million
Q1 2023

Jul 14, 2023

BUY
$74.68 - $85.82 $329,413 - $378,552
4,411 Added 45.32%
14,143 $1.15 Million
Q4 2022

Jan 26, 2023

SELL
$65.42 - $99.31 $610,761 - $927,158
-9,336 Reduced 48.96%
9,732 $0
Q3 2022

Oct 17, 2022

BUY
$80.24 - $95.27 $88,424 - $104,987
1,102 Added 6.13%
19,068 $1.58 Million
Q2 2022

Jul 19, 2022

BUY
$76.05 - $123.38 $302,602 - $490,929
3,979 Added 28.45%
17,966 $1.44 Million
Q1 2022

Apr 20, 2022

BUY
$108.37 - $120.0 $620,093 - $686,640
5,722 Added 69.23%
13,987 $1.58 Million
Q4 2021

Jan 19, 2022

BUY
$94.5 - $116.95 $781,042 - $966,591
8,265 New
8,265 $940,000

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $14.4B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Sippican Capital Advisors Portfolio

Follow Sippican Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.